Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

150.36
+2.181.47%
Post-market: 150.360.00000.00%16:31 EDT
Volume:2.08M
Turnover:311.88M
Market Cap:286.89B
PE:21.03
High:150.75
Open:150.25
Low:149.56
Close:148.18
52wk High:170.46
52wk Low:97.72
Shares:1.91B
Float Shares:1.82B
Volume Ratio:1.44
T/O Rate:0.11%
Dividend:4.67
Dividend Rate:3.10%
EPS(TTM):7.15
EPS(LYR):7.15
ROE:30.81%
ROA:11.14%
PB:6.22
PE(LYR):21.03

Loading ...

Novartis completes acquisition of Avidity Biosciences

TIPRANKS
·
Feb 27

Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy

GlobeNewswire
·
Feb 27

Novartis Says EMA Panel Recommends Remibrutinib for Chronic Spontaneous Urticaria

MT Newswires Live
·
Feb 27

Novartis receives positive CHMP opinion for remibrutinib in CSU

TIPRANKS
·
Feb 27

Novartis to build radioligand therapy site in Denton, Texas

TIPRANKS
·
Feb 25

COLUMN-Novartis quietly settles Henrietta Lacks suit as family’s legal push gains steam

Reuters
·
Feb 24

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
Feb 24

Novartis to Divest Majority Stake in Indian Subsidiary for $159 Million

Deep News
·
Feb 20

Trump Asserts Novartis Establishing Eleven Manufacturing Plants in the United States

Deep News
·
Feb 20

Unnatural Products in Pact With Novartis to Develop Macrocyclic Peptide Therapeutics

Dow Jones
·
Feb 18

U.S. RESEARCH ROUNDUP-Brixmor Property, Mohawk Industries, UDR

Reuters
·
Feb 17

Novartis on Track for Record High Closing -- Data Talk

Dow Jones
·
Feb 14

Novartis Says Vanrafia Late-Stage Data Support Slowing of Kidney Function Decline in IgA Nephropathy Patients

MT Newswires Live
·
Feb 13

Novartis price target raised to CHF 135 from CHF 125 at JPMorgan

TIPRANKS
·
Feb 13

Novartis’ treatment of progressive supranuclear palsy granted orphan designation

TIPRANKS
·
Feb 11

Correction to Super Bowl Ads Article on Feb. 6 and Feb. 7 -- WSJ

Dow Jones
·
Feb 11

Novartis downgraded to Hold from Buy at DZ Bank

TIPRANKS
·
Feb 10

Novartis breaks ground on biomedical research center in San Diego

TIPRANKS
·
Feb 07

Blood Tests and Better-for-You Soda: Super Bowl Ads May Be Healthiest Yet -- WSJ

Dow Jones
·
Feb 06

Novartis Submits Application in China for Groundbreaking Autoimmune Drug

Stock News
·
Feb 06